³ÉÈËVRÊÓƵ

David Langlais is an Associate Professor in the Departments of Human Genetics and Microbiology & Immunology at ³ÉÈËVRÊÓƵ, and Principal Investigator at the Dahdaleh Institute of Genomic Medicine. He completed his Ph.D. with honors in Molecular Biology in 2011 at the IRCM, where he studied the complex transcriptional regulation at play in the immuno-neuroendocrine interface. Dr Langlais then pursued postdoctoral research in Dr Philippe Gros’ lab at ³ÉÈËVRÊÓƵ. His research investigates the role of critical transcription factors in the epigenetic and transcriptional control of normal and pathologic immune responses. Dr Langlais has received multiple awards, including the Milstein Young Investigator Award from the International Cytokine and Interferon Society and his research was recognized in the Top 10 Discoveries of the year by Quebec Science in 2018 and 2022. His current research is founded on functional genomics, bioinformatics, genome editing and molecular biology methods to explain the transcriptional mechanisms involved in normal and pathological inflammation, aiming to identify and validate novel therapeutic targets for inflammatory diseases.